Scots-Knight Denise — SEC Form 4 filings
SEC reporting owner CIK 1297000. 10 Form 4 filings on record with FilingPulse; latest filed 2026-05-26.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-01-26 to 2026-05-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 2 filings — 221,642 shares, $844,909 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 92,273 shares @ $3.39 ($313,101) in Mereo BioPharma Group plc, filed 2024-06-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Mereo BioPharma Group plc (MREO) | Chief Executive Officer, Director | 7 | — | 4 legs · 221,642 sh · $844,909 | 9 |
| Elanco Animal Health Inc (ELAN) | Director | 3 | — | — | 4 |
Form 4 filings — Scots-Knight Denise
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-26 | 4 | Elanco Animal Health Inc (ELAN) | Grant/award (A): 4,678 @ $0 · Grant/award (A): 12,196 @ $0 | EDGAR |
| 2026-02-02 | 4 | Mereo BioPharma Group plc (MREO) | Grant/award (A): 1,035,000 (derivative) @ $0 · Grant/award (A): 345,000 (derivative) @ $0 · Grant/award (A): 480,000 (derivative) @ $0 | EDGAR |
| 2025-12-02 | 4 | Elanco Animal Health Inc (ELAN) | Grant/award (A): 10,314 @ $0 | EDGAR |
| 2025-01-28 | 4 | Mereo BioPharma Group plc (MREO) | Grant/award (A): 825,000 (derivative) @ $0 | EDGAR |
| 2024-12-03 | 4 | Elanco Animal Health Inc (ELAN) | Grant/award (A): 18,169 @ $0 | EDGAR |
| 2024-09-16 | 4 | Mereo BioPharma Group plc (MREO) | Sale (S): 28,611 @ $4.47 · Sale (S): 60,046 @ $4.22 | EDGAR |
| 2024-09-13 | 4 | Mereo BioPharma Group plc (MREO) | Option exercise (M): 188,060 @ $0 · Option exercise (M): 188,060 (derivative) @ $0 | EDGAR |
| 2024-06-27 | 4 | Mereo BioPharma Group plc (MREO) | Sale (S): 40,712 @ $3.69 · Sale (S): 92,273 @ $3.39 | EDGAR |
| 2024-06-25 | 4 | Mereo BioPharma Group plc (MREO) | Option exercise (M): 282,090 @ $0 · Option exercise (M): 282,090 (derivative) @ $0 | EDGAR |
| 2024-01-26 | 4 | Mereo BioPharma Group plc (MREO) | Grant/award (A): 850,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1297000 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →